E22 Hyperfunction of pituitary gland
E22 is the ICD-10-CM code family for Hyperfunction of pituitary gland: 5 codes, 4 of which can lead a home health claim.
Codes in family
5
Can lead a claim
4
Cannot lead a claim
1
What CMS assigns to E22
4 of the 5 codes group to MMTA - Endocrine; 1 is assigned no clinical group. None of the 5 is assigned a comorbidity subgroup. 4 of the 5 can lead a claim.
Every code in E22
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| E22.0 | Acromegaly and pituitary gigantism | Can lead a claim | I | None |
| E22.1 | Hyperprolactinemia | Can lead a claim | I | None |
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone | Can lead a claim | I | None |
| E22.8 | Other hyperfunction of pituitary gland | Can lead a claim | I | None |
| E22.9 | Hyperfunction of pituitary gland, unspecified | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | None |
Sources: CMS HH PPS Grouper Software (opens in a new tab) v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 (opens in a new tab) code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.